Stratification of Breast Cancer by Integrating Gene Expression Data and Clinical Variables

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Zongzhen HeYuanyuan Zhang


Breast cancer is a heterogeneous disease. Although gene expression profiling has led to the definition of several subtypes of breast cancer, the precise discovery of the subtypes remains a challenge. Clinical data is another promising source. In this study, clinical variables are utilized and integrated to gene expressions for the stratification of breast cancer. We adopt two phases: gene selection and clustering, where the integration is in the gene selection phase; only genes whose expressions are most relevant to each clinical variable and least redundant among themselves are selected for further clustering. In practice, we simply utilize maximum relevance minimum redundancy (mRMR) for gene selection and k-means for clustering. We compare the results of our method with those of two commonly used only expression-based breast cancer stratification methods: prediction analysis of microarray 50 (PAM50) and highest variability (HV). The result is that our method outperforms them in identifying subtypes significantly associated with five-year survival and recurrence time. Specifically, our method identified recurrence-associated breast cancer subtypes that were not identified by PAM50 and HV. Additionally, our analysis discovered ...Continue Reading


Apr 23, 2020·Frontiers in Genetics·Alessandra Jordano ConforteFabrício Alves Barbosa da Silva


Apr 20, 2001·Proceedings of the National Academy of Sciences of the United States of America·V G TusherG Chu
Sep 13, 2001·Proceedings of the National Academy of Sciences of the United States of America·Therese SørlieA L Børresen-Dale
Jun 28, 2003·Proceedings of the National Academy of Sciences of the United States of America·Therese SorlieDavid Botstein
May 1, 2004·BMJ : British Medical Journal·J Martin Bland, Douglas G Altman
Dec 2, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Therese Sørlie
Aug 27, 2005·IEEE Transactions on Pattern Analysis and Machine Intelligence·Hanchuan PengChris Ding
May 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bernard FisherEdwin R Fisher
Feb 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joel S ParkerPhilip S Bernard
Feb 26, 2010·The Lancet Oncology·Britta WeigeltJorge S Reis-Filho
Jun 23, 2010·Breast Cancer Research : BCR·Karolina HolmMarkus Ringnér
Jul 22, 2010·Endocrine-related Cancer·Marion T Weigel, Mitch Dowsett
Oct 4, 2011·The Journal of Clinical Investigation·Nicholas R Bertos, Morag Park
Sep 17, 2013·Nature Methods·Matan HofreeTrey Ideker
Feb 7, 2014·Scientific Reports·Zhaoqi LiuShihua Zhang
Aug 13, 2014·World Journal of Clinical Oncology·Ozlem Yersal, Sabri Barutca
Nov 14, 2014·Nucleic Acids Research·Mary GoldmanJingchun Zhu
Dec 6, 2016·Nature Medicine·Andrew T DrysdaleConor Liston
Jul 24, 2017·The American Journal of Pathology·Hege G RussnesCarlos Caldas

Related Concepts

Gene Expression Regulation, Neoplastic
Evaluation and Management of Patient at Home
FAM3C protein, human
Sequence Determinations, RNA
Study of Physiologic Variables
Survival Analysis

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.